S&P 500
5.307,01 -14,40 (-0,27%) Nasdaq
16.801,54 -31,08 (-0,18%) NIKKEI 225
38.913,48 +296,38 (+0,77%) Dólar/Euro
1,0832 +0,0005 (+0,04%) Petróleo Brent
81,48 -0,42 (-0,51%) Bitcoin EUR
64.121,07 -457,73 (-0,71%)
Daxor Corporation (DXR)
Daxor Corporation
109 Meco Lane
Oak Ridge, TN 37830
United States
https://www.daxor.com
Sector(es): Healthcare
Sector: Medical Instruments & Supplies
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Michael Richard Feldschuh | Chairman, President & CEO | 100k | N/A | 1969 |
| Mr. Jonathan Adam Feldschuh | Chief Scientific Officer & Director | 127,92k | N/A | 1965 |
| Mr. Robert J. Michel CPA, CPA, M.B.A. | CFO, Chief Compliance Officer & Corporate Secretary | N/A | N/A | 1957 |
| Ms. Linda Cooper | Vice President of Development & Operations | N/A | N/A | N/A |
| Ms. Kathryn A. Kornafel | Senior VP of Marketing & Commercial Development | N/A | N/A | N/A |
| Mr. Guido Manzo | Vice President of Sales | N/A | N/A | N/A |
| Ms. Jean Oertel | Senior Vice President Commercialization & Customer Experience | N/A | N/A | N/A |
Descripción
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Gobierno corporativo
El ISS Governance QualityScore de Daxor Corporation, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
